- Home
- TARA vs EUDA Comparison
TARA vs EUDA Comparison
Compare TARA & EUDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- EUDA
- Stock Information
- Founded
- TARA N/A
- EUDA 2021
- Country
- TARA United States
- EUDA Singapore
- Employees
- TARA N/A
- EUDA N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- EUDA Blank Checks
- Sector
- TARA Health Care
- EUDA Finance
- Exchange
- TARA Nasdaq
- EUDA Nasdaq
- Market Cap
- TARA 158.2M
- EUDA 158.3M
- IPO Year
- TARA N/A
- EUDA N/A
- Fundamental
- Price
- TARA $3.72
- EUDA $3.99
- Analyst Decision
- TARA Strong Buy
- EUDA
- Analyst Count
- TARA 3
- EUDA 0
- Target Price
- TARA $22.67
- EUDA N/A
- AVG Volume (30 Days)
- TARA 270.4K
- EUDA 103.3K
- Earning Date
- TARA 03-12-2025
- EUDA 01-01-0001
- Dividend Yield
- TARA N/A
- EUDA N/A
- EPS Growth
- TARA N/A
- EUDA N/A
- EPS
- TARA N/A
- EUDA N/A
- Revenue
- TARA N/A
- EUDA $3,811,496.00
- Revenue This Year
- TARA N/A
- EUDA $121.80
- Revenue Next Year
- TARA N/A
- EUDA $78.17
- P/E Ratio
- TARA N/A
- EUDA N/A
- Revenue Growth
- TARA N/A
- EUDA N/A
- 52 Week Low
- TARA $1.60
- EUDA $1.20
- 52 Week High
- TARA $10.48
- EUDA $6.30
- Technical
- Relative Strength Index (RSI)
- TARA 33.05
- EUDA 48.07
- Support Level
- TARA $3.91
- EUDA $3.96
- Resistance Level
- TARA $4.05
- EUDA $4.49
- Average True Range (ATR)
- TARA 0.29
- EUDA 0.33
- MACD
- TARA -0.07
- EUDA 0.03
- Stochastic Oscillator
- TARA 0.00
- EUDA 49.50
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About EUDA EUDA Health Holdings Limited
EUDA Health Holdings Ltd is a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem aimed at making healthcare affordable and accessible, The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians, and predicts optimal treatment outcomes. The company caters to all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. The company operates in two segments namely Medical services and property management services, out of which the company derives its maximum revenue from Medical services.